Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Deshayes

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Rheumatology International|October 23, 2025
Impact of gastrointestinal involvement on mortality and malnutrition in systemic sclerosis: an observational cohort of 135 patientsMarie Bader, Achille Aouba, Rémy Morello, et al.
Rheumatology (Oxford, England)|March 18, 2024
Frequency and characteristics of severe relapses in giant cell arteritisNicolas Lozachmeur, Anael Dumont, Samuel Deshayes, et al.
Seminars in Arthritis and Rheumatism|March 21, 2020
Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control studyAnaël Dumont, Anaïs Lecannuet, Jonathan Boutemy, et al.
Innate Immunity|September 3, 2019
In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosisClémence Gorlier, Jérémie Sellam, Ludivine Laurans, et al.
Innate Immunity|April 1, 2020
Response to Letter to the EditorClémence Gorlier, Jérémie Sellam, Ludivine Laurans, et al.
European Journal of Internal Medicine|April 5, 2024
Evolution and outcomes of aortic dilations in giant cell arteritisSophie Gallou, Christian Agard, Anael Dumont, et al.
Rheumatology (Oxford, England)|March 14, 2021
Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic reviewJérémie Delaleu, Samuel Deshayes, Francois Rodrigues, et al.
Oncoimmunology|September 18, 2018
Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatmentFréderic Franconieri, Samuel Deshayes, Hubert de Boysson, et al.
Frontiers in Medicine|December 3, 2021
Impact of Giant Cell Arteritis and Its Treatment on the Patient's Quality of Life: A Single-Center Self-Assessment StudyHubert de Boysson, Clivia Barakat, Anael Dumont, et al.
Rheumatology (Oxford, England)|December 17, 2021
Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse eventsHubert de Boysson, Clivia Barakat, Anael Dumont, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Rheumatology International|October 23, 2025
Impact of gastrointestinal involvement on mortality and malnutrition in systemic sclerosis: an observational cohort of 135 patientsMarie Bader, Achille Aouba, Rémy Morello, et al.
Rheumatology (Oxford, England)|March 18, 2024
Frequency and characteristics of severe relapses in giant cell arteritisNicolas Lozachmeur, Anael Dumont, Samuel Deshayes, et al.
Seminars in Arthritis and Rheumatism|March 21, 2020
Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control studyAnaël Dumont, Anaïs Lecannuet, Jonathan Boutemy, et al.
Innate Immunity|September 3, 2019
In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosisClémence Gorlier, Jérémie Sellam, Ludivine Laurans, et al.
Innate Immunity|April 1, 2020
Response to Letter to the EditorClémence Gorlier, Jérémie Sellam, Ludivine Laurans, et al.
European Journal of Internal Medicine|April 5, 2024
Evolution and outcomes of aortic dilations in giant cell arteritisSophie Gallou, Christian Agard, Anael Dumont, et al.
Rheumatology (Oxford, England)|March 14, 2021
Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic reviewJérémie Delaleu, Samuel Deshayes, Francois Rodrigues, et al.
Oncoimmunology|September 18, 2018
Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatmentFréderic Franconieri, Samuel Deshayes, Hubert de Boysson, et al.
Frontiers in Medicine|December 3, 2021
Impact of Giant Cell Arteritis and Its Treatment on the Patient's Quality of Life: A Single-Center Self-Assessment StudyHubert de Boysson, Clivia Barakat, Anael Dumont, et al.
Rheumatology (Oxford, England)|December 17, 2021
Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse eventsHubert de Boysson, Clivia Barakat, Anael Dumont, et al.
Pageof 8